Factors reducing the effectiveness for pregnant women of receiving any IPTp-SP by DOT when of eligible gestation during an ANC visit.

<p>Note: SP, sulfadoxine-pyrimethamine; ANC, antenatal clinic; DOT, directly observed treatment; IPTp, intermittent preventive treatment.</p

Factors influencing reduced effectiveness of intermediate processes in the delivery of IPTp-SP, IPTp-SP by DOT and ITNs (in the presence of required stock).

<p>Notes:</p><p>SP, Sulfadoxine-pyrimethamine; ITN, Insecticide Treated Net; CSCom, Community health center; CSRef, Reference health center; ANC, Antenatal Clinic; DOT, Direct Observed Treatment; IPTp, Intermittent Preventive Treatment; SES, Socio-economic Status; CFA, Franc XOF;</p><p>↑, arrow indicating high level; ↓, arrow indicating low level.</p

Diagnosis categories for ineffective implementation of the delivery of IPTp-SP and ITNs based upon quotes of health workers.

<p>Diagnosis categories for ineffective implementation of the delivery of IPTp-SP and ITNs based upon quotes of health workers.</p

Cumulative effectiveness of delivery of ITNs during 1^st ANC visit by women of any gestation.

<p>Intermediate process 1 = attend ANC; Intermediate process 2 = offered ITN during ANC consultation; Intermediate process 3 = take ITN.</p

Characteristics of health facilities.

1<p>attending for the first time during the current pregnancy;</p>2<p>attending for the first time or multiple times during the current pregnancy; *during 2008.</p><p>CSRef; Reference Health Centre; CSCom, Community Health Centre; ANC, antenatal clinic; Km, kilometre;</p><p>No., number.</p

Unadjusted and adjusted predictors of being given SP by DOT amongst those who were given IPTp-SP in consultation at CSComs.

<p>Notes:</p><p>SP, Sulphadoxine-pyrimethamine; DOT, Direct Observed Treatment; n, number of events; OR, Odds Ratio, CI, Confidence Interval; SES, Socio-economic Status; Na, not available.</p

Cumulative effectiveness of delivery of IPTp during 1^st ANC visit by women 4 to 8 months pregnant.

<p>Intermediate process 1 = attend ANC consultation; Intermediate process 2 = given SP during ANC consultation; Intermediate process 3 = given 3 tablets SP; Intermediate process 4 = take SP by DOT (A); or take SP by DOT or have 3 tablets on exit and can report correctly how they will be taken (B).</p

Design effect and intra cluster correlation of delivery processes amongst the CSRef plus CSComs and the CSComs.

<p>Notes:</p><p>CSCom, Community Health Centre; CSRef, Reference Health Centre; N = sample size; DE, Design Effect; ICC, intra-class correlation, SP, Sulphadoxine-pyrimethamine; DOT, Direct Observed Treatment; ITN, Insecticide Treated Nets.</p

Descriptions of the potential predictors included in the univariate analyses.

<p>Source Key.</p><p>1 = response of pregnant woman to a question by a fieldworker; 2 = response of pregnant woman to a question from a health worker; 3 = action observed by fieldworker; 4 = heard by a fieldworker during observations; 5 = written information/data observed by fieldworker; PMTC, Prevention of Mother to Child Transmission; ITN, Insecticide Treated Net; STI, sexual transmitted infection; UTI, Urinary Tract Infection; HIV, human immunodeficiency virus; ANC, Antenatal clinic;</p

Unadjusted and adjusted predictors of receiving SP during consultation.

<p>Notes:</p><p>CSRef, Reference Health Center; CSCom, Community Health Cebter; OR, Odds Ratio; CI, Confidence Interval; n, number of events; PMTCT, Prevention of Mother to Child Transmission; ANC, Antenatal Clinic; ITN, Insecticide Treated Net; Prescr, prescription; na, not applicable;</p